During the past decade, Kirk Barber Research conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 15 clinical trials were completed, i.e. on average, 93.8% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 11 clinical trials were completed. i.e. 366.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kirk Barber Research" #1 sponsor was "Eli Lilly and Company" with 4 trials, followed by "Pfizer" with 4 trials sponsored, "Innovaderm Research Inc." with 3 trials sponsored, "Amgen" with 2 trials sponsored and "Concert Pharmaceuticals" with 2 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kirk Barber Research" #1 collaborator was "Amgen" with 2 trials as a collaborator, "Incyte Corporation" with 2 trials as a collaborator, "Immune Tolerance Network (ITN)" with 1 trials as a collaborator and "Janssen-Ortho LLC" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Kirk Barber Research" are "Psoriasis" (12 trials), "Acne Vulgaris" (4 trials), "Alopecia Areata" (2 trials), "Atopic Dermatitis" (2 trials) and "Dermatitis, Atopic" (2 trials). Many other conditions were trialed in "Kirk Barber Research" in a lesser frequency.

Most popular intervention types in "Kirk Barber Research" are "Drug" (25 trials), "Other" (6 trials), "Biological" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Apremilast" (2 trials), "Baricitinib" (2 trials), "CP-690,550" (2 trials) and "Ustekinumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Kirk Barber Research" are 29 trials for "All" genders.

Currently, there are NaN active trials in "Kirk Barber Research". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 23 completed trials in Kirk Barber Research, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Kirk Barber Research, 3 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".